Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Cookson

Showing results (361-370 of 388) with videos related to

Pageof 39
Sort By:
BMJ Open|September 28, 2017
When is a randomised controlled trial health equity relevant? Development and validation of a conceptual frameworkJ Jull, M Whitehead, M Petticrew, et al.
NPJ Dementia|June 22, 2026
Haplotype-resolved DNA methylation at the <i>APOE</i> locus identifies allele-specific epigenetic signatures relevant to Alzheimer's disease riskRylee M Genner, Melissa Meredith, Kensuke Daida, et al.
Science Signaling|February 24, 2026
Temporal proteomic and phosphoproteomic dynamics during neuronal differentiation in the reference iPSC line KOLF2.1JYing Hao, Ziyi Li, Erika Lara, et al.
Journal of Parkinson'S Disease|April 5, 2024
Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson's Disease: The International Linked Clinical Trials InitiativeRichard K Wyse, Tom Isaacs, Roger A Barker, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Is <i>SORL1</i> a common genetic target across neurodegenerative diseases?: A multi-ancestry biobank scale assessmentMarzieh Khani, Sheila N Yeboah, Catalina Cerquera-Cleves, et al.
EMBO Molecular Medicine|July 26, 2021
LAG3 is not expressed in human and murine neurons and does not modulate α-synucleinopathiesMarc Emmenegger, Elena De Cecco, Marian Hruska-Plochan, et al.
Brain : a Journal of Neurology|May 26, 2026
Is SORL1 a common genetic target across neurodegenerative diseases? A multi-ancestry biobank studyMarzieh Khani, Sheila N Yeboah, Catalina Cerquera-Cleves, et al.
Brain : a Journal of Neurology|September 8, 2022
Regulation of mitophagy by the NSL complex underlies genetic risk for Parkinson's disease at 16q11.2 and MAPT H1 lociMarc P M Soutar, Daniela Melandri, Benjamin O'Callaghan, et al.
JAMA Neurology|July 25, 2018
Frequency of Loss of Function Variants in LRRK2 in Parkinson DiseaseCornelis Blauwendraat, Xylena Reed, Demis A Kia, et al.
Biorxiv : the Preprint Server for Biology|April 29, 2026
The complete genome of the KOLF2.1J reference iPSC linePilar Alvarez Jerez, Arang Rhie, Juhyun Kim, et al.
Pageof 39

Showing results (361-370 of 388) with videos related to

Sort By:
Pageof 39
BMJ Open|September 28, 2017
When is a randomised controlled trial health equity relevant? Development and validation of a conceptual frameworkJ Jull, M Whitehead, M Petticrew, et al.
NPJ Dementia|June 22, 2026
Haplotype-resolved DNA methylation at the <i>APOE</i> locus identifies allele-specific epigenetic signatures relevant to Alzheimer's disease riskRylee M Genner, Melissa Meredith, Kensuke Daida, et al.
Science Signaling|February 24, 2026
Temporal proteomic and phosphoproteomic dynamics during neuronal differentiation in the reference iPSC line KOLF2.1JYing Hao, Ziyi Li, Erika Lara, et al.
Journal of Parkinson'S Disease|April 5, 2024
Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson's Disease: The International Linked Clinical Trials InitiativeRichard K Wyse, Tom Isaacs, Roger A Barker, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Is <i>SORL1</i> a common genetic target across neurodegenerative diseases?: A multi-ancestry biobank scale assessmentMarzieh Khani, Sheila N Yeboah, Catalina Cerquera-Cleves, et al.
EMBO Molecular Medicine|July 26, 2021
LAG3 is not expressed in human and murine neurons and does not modulate α-synucleinopathiesMarc Emmenegger, Elena De Cecco, Marian Hruska-Plochan, et al.
Brain : a Journal of Neurology|May 26, 2026
Is SORL1 a common genetic target across neurodegenerative diseases? A multi-ancestry biobank studyMarzieh Khani, Sheila N Yeboah, Catalina Cerquera-Cleves, et al.
Brain : a Journal of Neurology|September 8, 2022
Regulation of mitophagy by the NSL complex underlies genetic risk for Parkinson's disease at 16q11.2 and MAPT H1 lociMarc P M Soutar, Daniela Melandri, Benjamin O'Callaghan, et al.
JAMA Neurology|July 25, 2018
Frequency of Loss of Function Variants in LRRK2 in Parkinson DiseaseCornelis Blauwendraat, Xylena Reed, Demis A Kia, et al.
Biorxiv : the Preprint Server for Biology|April 29, 2026
The complete genome of the KOLF2.1J reference iPSC linePilar Alvarez Jerez, Arang Rhie, Juhyun Kim, et al.
Pageof 39